Enoxacin-based derivatives: antimicrobial and antibiofilm agent: a biology-oriented drug synthesis (BIODS) approach

Future Med Chem. 2022 Jul;14(13):947-962. doi: 10.4155/fmc-2022-0065. Epub 2022 Jun 13.

Abstract

Background: To find alternative molecules against Klebsiella pneumonia, Proteus mirabilis and methicillin-resistant Staphylococcus aureus, new enoxacin derivatives were synthesized and screened. Methods: All derivatives exhibited promising antibacterial activities as compared to standard enoxacin (2 μg/ml) and standard cefixime (82 μg/ml). Compounds 2, 3 and 5 significantly downregulated the gene expression of biofilm-forming genes. Conclusion: Based on our results, these molecules may serve as potential drug candidates to cure several bacterial infections in the future.

Keywords: DNA–gyrases; Gram-negative; Gram-positive; antibacterial; antibiofilm; derivatives; enoxacin; fluorescence microscopy; spectroscopic analysis; synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Biofilms
  • Biology
  • Enoxacin / pharmacology
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Enoxacin